Stratec: An exciting OEM partner in the diagnostics market with a moderate valuation
Reading Time: 2 minutes
The stock of Stratec is worth a look. It is an OEM partner that specializes in the development and manufacture of fully automated analyzer systems. These systems are primarily developed for customers in clinical diagnostics and adjacent markets such as biotechnology and life sciences. The "Development & Services" segment is experiencing strong growth, increasing by around 20% in the last quarter. It encompasses all services related to the development of new products and customer-specific solutions in in vitro diagnostics. The potential is...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
